These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 17510430

  • 1. Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response.
    Ferrario A, Rucker N, Wong S, Luna M, Gomer CJ.
    Cancer Res; 2007 May 15; 67(10):4989-95. PubMed ID: 17510430
    [Abstract] [Full Text] [Related]

  • 2. Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors.
    Ferrario A, Fisher AM, Rucker N, Gomer CJ.
    Cancer Res; 2005 Oct 15; 65(20):9473-8. PubMed ID: 16230411
    [Abstract] [Full Text] [Related]

  • 3. Optimization of photodynamic therapy response by survivin gene knockdown in human metastatic breast cancer T47D cells.
    Cogno IS, Vittar NB, Lamberti MJ, Rivarola VA.
    J Photochem Photobiol B; 2011 Sep 02; 104(3):434-43. PubMed ID: 21641815
    [Abstract] [Full Text] [Related]

  • 4. CHOP activation by photodynamic therapy increases treatment induced photosensitization.
    Wong S, Luna M, Ferrario A, Gomer CJ.
    Lasers Surg Med; 2004 Sep 02; 35(5):336-41. PubMed ID: 15611953
    [Abstract] [Full Text] [Related]

  • 5. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma.
    Ferrario A, von Tiehl KF, Rucker N, Schwarz MA, Gill PS, Gomer CJ.
    Cancer Res; 2000 Aug 01; 60(15):4066-9. PubMed ID: 10945611
    [Abstract] [Full Text] [Related]

  • 6. Photodynamic therapy-mediated oxidative stress can induce expression of heat shock proteins.
    Gomer CJ, Ryter SW, Ferrario A, Rucker N, Wong S, Fisher AM.
    Cancer Res; 1996 May 15; 56(10):2355-60. PubMed ID: 8625311
    [Abstract] [Full Text] [Related]

  • 7. Photodynamic therapy-mediated oxidative stress as a molecular switch for the temporal expression of genes ligated to the human heat shock promoter.
    Luna MC, Ferrario A, Wong S, Fisher AM, Gomer CJ.
    Cancer Res; 2000 Mar 15; 60(6):1637-44. PubMed ID: 10749134
    [Abstract] [Full Text] [Related]

  • 8. Targeting the 90 kDa heat shock protein improves photodynamic therapy.
    Ferrario A, Gomer CJ.
    Cancer Lett; 2010 Mar 28; 289(2):188-94. PubMed ID: 19733005
    [Abstract] [Full Text] [Related]

  • 9. The heat-shock protein 90 inhibitor, geldanamycin, induces apoptotic cell death in Epstein-Barr virus-positive NK/T-cell lymphoma by Akt down-regulation.
    Jeon YK, Park CH, Kim KY, Li YC, Kim J, Kim YA, Paik JH, Park BK, Kim CW, Kim YN.
    J Pathol; 2007 Oct 28; 213(2):170-9. PubMed ID: 17768706
    [Abstract] [Full Text] [Related]

  • 10. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
    Rahman KW, Li Y, Wang Z, Sarkar SH, Sarkar FH.
    Cancer Res; 2006 May 01; 66(9):4952-60. PubMed ID: 16651453
    [Abstract] [Full Text] [Related]

  • 11. Tailor-made approach to photodynamic therapy in the treatment of cancer based on Bcl-2 photodamage.
    Usuda J, Hirata T, Ichinose S, Ishizumi T, Inoue T, Ohtani K, Maehara S, Yamada M, Tsutsui H, Okunaka T, Kato H, Ikeda N.
    Int J Oncol; 2008 Oct 01; 33(4):689-96. PubMed ID: 18813781
    [Abstract] [Full Text] [Related]

  • 12. Rituximab and 17-allylamino-17-demethoxygeldanamycin induce synergistic apoptosis in B-cell chronic lymphocytic leukaemia.
    Johnson AJ, Wagner AJ, Cheney CM, Smith LL, Lucas DM, Guster SK, Grever MR, Lin TS, Byrd JC.
    Br J Haematol; 2007 Dec 01; 139(5):837-44. PubMed ID: 17949452
    [Abstract] [Full Text] [Related]

  • 13. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
    Peng Q, Warloe T, Moan J, Godal A, Apricena F, Giercksky KE, Nesland JM.
    Cancer Res; 2001 Aug 01; 61(15):5824-32. PubMed ID: 11479222
    [Abstract] [Full Text] [Related]

  • 14. Geldanamycin and 17-allylamino-17-demethoxygeldanamycin potentiate the in vitro and in vivo radiation response of cervical tumor cells via the heat shock protein 90-mediated intracellular signaling and cytotoxicity.
    Bisht KS, Bradbury CM, Mattson D, Kaushal A, Sowers A, Markovina S, Ortiz KL, Sieck LK, Isaacs JS, Brechbiel MW, Mitchell JB, Neckers LM, Gius D.
    Cancer Res; 2003 Dec 15; 63(24):8984-95. PubMed ID: 14695217
    [Abstract] [Full Text] [Related]

  • 15. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells.
    Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M, Nam S, Eweis I, Diaz N, Sullivan D, Yoder S, Enkemann S, Eschrich S, Lee JH, Beam CA, Cheng J, Minton S, Muro-Cacho CA, Jove R.
    Clin Cancer Res; 2006 Jan 01; 12(1):11-9. PubMed ID: 16397018
    [Abstract] [Full Text] [Related]

  • 16. Disruption of the inhibitor of apoptosis protein survivin sensitizes Bcr-abl-positive cells to STI571-induced apoptosis.
    Wang Z, Sampath J, Fukuda S, Pelus LM.
    Cancer Res; 2005 Sep 15; 65(18):8224-32. PubMed ID: 16166298
    [Abstract] [Full Text] [Related]

  • 17. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels.
    Lu M, Strohecker A, Chen F, Kwan T, Bosman J, Jordan VC, Cryns VL.
    Clin Cancer Res; 2008 May 15; 14(10):3168-76. PubMed ID: 18483385
    [Abstract] [Full Text] [Related]

  • 18. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs.
    Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, Reed JC.
    Cancer Res; 1998 Dec 01; 58(23):5315-20. PubMed ID: 9850056
    [Abstract] [Full Text] [Related]

  • 19. Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo.
    Zhang M, Mukherjee N, Bermudez RS, Latham DE, Delaney MA, Zietman AL, Shipley WU, Chakravarti A.
    Prostate; 2005 Aug 01; 64(3):293-302. PubMed ID: 15754318
    [Abstract] [Full Text] [Related]

  • 20. Molecular determinants of photodynamic therapy for lung cancers.
    Usuda J, Ichinose S, Ishizumi T, Ohtani K, Inoue T, Maehara S, Imai K, Shima K, Ohira T, Kato H, Ikeda N.
    Lasers Surg Med; 2011 Sep 01; 43(7):591-9. PubMed ID: 22057486
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.